<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20210911</date><key>pmc.key</key><document><id>7523492</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.1007/s00296-020-04710-5</infon><infon key="article-id_pmc">7523492</infon><infon key="article-id_pmid">32995894</infon><infon key="article-id_publisher-id">4710</infon><infon key="fpage">2031</infon><infon key="issue">12</infon><infon key="kwd">Twitter SARS-CoV-2 COVID-19 Rheumatology Hashtag</infon><infon key="license">Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.</infon><infon key="lpage">2037</infon><infon key="name_0">surname:Ruffer;given-names:Nikolas</infon><infon key="name_1">surname:Knitza;given-names:Johannes</infon><infon key="name_2">surname:Krusche;given-names:Martin</infon><infon key="section_type">TITLE</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="volume">40</infon><infon key="year">2020</infon><offset>0</offset><text>#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>79</offset><text>Social media services, such as Twitter, offer great potential for a better understanding of rheumatic and musculoskeletal disorders (RMDs) and improved care in the field of rheumatology. This study examined the content and stakeholders associated with the Twitter hashtag #Covid4Rheum during the COVID-19 pandemic. The content analysis shows that Twitter connects stakeholders of the rheumatology community on a global level, reaching millions of users. Specifically, the use of hashtags on Twitter assists digital crowdsourcing projects and scientific collaboration, as exemplified by the COVID-19 Global Rheumatology Alliance registry. Moreover, Twitter facilitates the distribution of scientific content, such as guidelines or publications. Finally, digital data mining enables the identification of hot topics within the field of rheumatology.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>927</offset><text>Electronic supplementary material</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>961</offset><text>The online version of this article (10.1007/s00296-020-04710-5) contains supplementary material, which is available to authorized users.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1098</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1111</offset><text>The use and influence of social media in rheumatology have increased rapidly in recent years. Via the use of hashtags (#), specific topics, individual persons or institutions, as well as projects and ideas, can be identified and linked to each other and therefore foster rapid digital exchange.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1406</offset><text>Social media is frequently used in the scientific rheumatology community to exchange and discuss information and opinions, and to promote meetings, projects or publications. Social media channels can, furthermore, be useful for expanding education and research perspectives. However, social media can be abused to broadcast misinformation, unethical promotion of content, and can enable unprofessional behavior. Therefore, the role of social media editing is becoming increasingly important. This includes not only filtering and promoting credible and expert-proven information, but also the activity of ethical guidance.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2028</offset><text>In the context of the COVID-19 pandemic, Twitter played a prominent role in moderating the scientific discourse, with subsequent implementation of research projects. New COVID-19-associated hashtags were created and frequently used by various stakeholders in the rheumatological community. For example, the hashtag #Covid4Rheum was first introduced by @ACR_Journals on March 13th 2020 and became an influential hashtags connecting COVID-19 and rheumatology related topics, such as the use of immunosuppressive drugs, the implementation of telemedicine, as well as the establishment and data distribution of the COVID-19 Global Rheumatology Alliance.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2678</offset><text>Applying digital data mining and crowdsourcing to social media offers new opportunities for scientific research. Via the use of data and text mining—a technology which can be applied to extract potentially valuable knowledge from large data sets - all Tweets related to #Covid4Rheum were identified and analysed.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2993</offset><text>Objective</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3003</offset><text>To examine the influence, content and stakeholders associated with the Twitter hashtag #Covid4Rheum during the COVID-19 pandemic.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>3133</offset><text>Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3141</offset><text>A two-step hashtag analysis of tweets associated with #Covid4Rheum between 13/03/2020 and 01/06/2020 was carried out. First, the Twitter analytics tool Vicinitas (https://vicinitas.io) provided basic tweet data (i.e. language), and calculated the engagement (the sum of intentional interactions in response to a post with a tracked hashtag) and influence (sum of followers of the tweet creators) of the tweets.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3552</offset><text>In a second step, two independent reviewers analysed the primary tweets (re-tweets and replies were excluded) for qualitative content analysis. Disagreement was resolved by consultation of a third independent reviewer.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3771</offset><text>Twitter user and content analysis definitions are illustrated in the Supplementary material A.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>3866</offset><text>Results</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>3874</offset><text>Basic tweet characteristics</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Language&lt;sup&gt;b&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Tweets&lt;sup&gt;c&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Percent&lt;sup&gt;c&lt;/sup&gt;&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; English&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;206&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;90.3 (206/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; German&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;9&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;3.9 (9/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Spanish&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;8&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;3.5 (8/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Arabian&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;4&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;1.7 (4/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Norwegian&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;4&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;1.7 (4/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Japanese&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt; &amp;lt; 1 (1/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Turkish&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt; &amp;lt; 1 (1/228)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>3902</offset><text>Tweet creators	Tweets	Percent	 	 Healthcare professional/researcher	110	44.9 (110/245)	 	 Scientific society	80	32.7 (80/245)	 	 Scientific journal	21	8.6 (21/245)	 	 Support group	16	6.5 (16/245)	 	 Research group	7	2.9 (7/245)	 	 Other	6	2.4 (6/245)	 	 Patient	5	2.0 (5/245)	 	</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Language&lt;sup&gt;b&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Tweets&lt;sup&gt;c&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Percent&lt;sup&gt;c&lt;/sup&gt;&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; English&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;206&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;90.3 (206/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; German&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;9&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;3.9 (9/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Spanish&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;8&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;3.5 (8/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Arabian&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;4&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;1.7 (4/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Norwegian&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;4&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;1.7 (4/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Japanese&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt; &amp;lt; 1 (1/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Turkish&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt; &amp;lt; 1 (1/228)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>4189</offset><text>Geolocation	Tweetsa	Percenta	 	 Argentina	1	0.4 (1/225)	 	 Australia	2	0.9 (2/225)	 	 Canada	6	2.7 (6/225)	 	 Columbia	4	1.8 (4/225)	 	 Germany	9	4.0 (9/225)	 	 India	4	1.8 (4/225)	 	 Ireland	1	0.4 (1/225)	 	 Jordan	7	3.1 (7/225)	 	 Norway	4	1.8 (4/225)	 	 Pakistan	2	0.9 (2/225)	 	 Peru	4	1.8 (4/225)	 	 Philippines	2	0.9 (2/225)	 	 Qatar	1	0.4 (1/225)	 	 Saudi Arabia	3	1.3 (3/225)	 	 Spain	3	1.3 (3/225)	 	 Turkey	1	0.4 (1/225)	 	 United Arab Emirates	3	1.3 (3/225)	 	 United Kingdom	18	8.0 (18/225)	 	 United States	150	66.7 (150/225)	 	</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Language&lt;sup&gt;b&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Tweets&lt;sup&gt;c&lt;/sup&gt;&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Percent&lt;sup&gt;c&lt;/sup&gt;&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; English&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;206&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;90.3 (206/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; German&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;9&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;3.9 (9/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Spanish&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;8&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;3.5 (8/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Arabian&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;4&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;1.7 (4/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Norwegian&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;4&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;1.7 (4/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Japanese&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt; &amp;lt; 1 (1/228)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Turkish&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt; &amp;lt; 1 (1/228)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>4750</offset><text>Languageb	Tweetsc	Percentc	 	 English	206	90.3 (206/228)	 	 German	9	3.9 (9/228)	 	 Spanish	8	3.5 (8/228)	 	 Arabian	4	1.7 (4/228)	 	 Norwegian	4	1.7 (4/228)	 	 Japanese	1	 &lt; 1 (1/228)	 	 Turkish	1	 &lt; 1 (1/228)	 	</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>4979</offset><text>aGeolocation was not available for all tweet creators</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>5033</offset><text>bLanguage was not available for all tweets (e.g. tweet exclusively comprised hashtags)</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>5120</offset><text>cTweets could include multiple languages</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5161</offset><text>The study period covers 2483 tweets (245 primary tweets, 2201 retweets, 37 replies) from 1397 users in total. Overall, #Covid4Rheum reached an engagement in 6916 users and an influence of 6,725,773 users. A total of 242 (9.8%) primary tweets from 78 users (19 different countries, 7 different languages) were included for content analysis. Most tweets were created by healthcare professionals and/or researchers (110/245; 44.9%), whereas patients (5/245; 2%) or support groups (16/245; 6.5%) rarely engaged with the hashtag. The vast majority of the primary tweets were created by professional Twitter users (218/245; 88.97%). English was the predominant language (206/228; 90.3%). Basic tweet characteristics are displayed in Table 1.</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>5898</offset><text>Tweet content analysis</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Management of RMD patients with COVID-19&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Tweets&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Percent&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Guideline/recommendation (scientific society)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;9&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;60.0 (9/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Recommendation (healthcare professional)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;5&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;33.3 (4/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Other&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;6.6 (1/15)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>5921</offset><text>Rheumatic and musculoskeletal diseases (RMD)	Tweetsa	Percenta	 	 Spondyloarthritis	8	44.4 (8/18)	 	 Systemic lupus erythematodes	8	44.4 (8/18)	 	 Rheumatoid Arthritis	7	38.3 (7/18)	 	 Psoriatic arthritis	6	33.3 (6/18)	 	 Sjögren’s syndrome	2	11.1 (2/18)	 	 Vasculitis	2	11.1 (2/18)	 	 Pediatric conditions	2	11.1 (2/18)	 	 Antiphospholipid syndrome	1	5.5 (1/18)	 	 Systemic sclerosis	1	5.5 (1/18)	 	</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Management of RMD patients with COVID-19&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Tweets&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Percent&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Guideline/recommendation (scientific society)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;9&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;60.0 (9/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Recommendation (healthcare professional)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;5&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;33.3 (4/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Other&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;6.6 (1/15)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>6333</offset><text>Therapeutic agentsb	Tweetsb	Percentb	 	 Hydroxychloroquine/chloroquine	41	64.1 (41/64)	 	 Tocilizumab	7	10.9 (7/64)	 	 Methotrexate	3	4.6 (3/64)	 	 Sarilumab	3	4.6 (3/64)	 	 Steroids	3	4.6 (3/64)	 	</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Management of RMD patients with COVID-19&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Tweets&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Percent&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Guideline/recommendation (scientific society)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;9&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;60.0 (9/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Recommendation (healthcare professional)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;5&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;33.3 (4/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Other&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;6.6 (1/15)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>6537</offset><text>Management of RMD patients without COVID-19	Tweets	Percent	 	 Guideline/recommendation (scientific society)	23	53.4 (23/43)	 	 Recommendation (healthcare professional)	17	39.5 (17/43)	 	 Other	3	6.9 (3/43)	 	</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Management of RMD patients with COVID-19&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Tweets&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Percent&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Guideline/recommendation (scientific society)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;9&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;60.0 (9/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Recommendation (healthcare professional)&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;5&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;33.3 (4/15)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt; Other&lt;/td&gt;&lt;td char=&quot;.&quot; align=&quot;char&quot;&gt;1&lt;/td&gt;&lt;td char=&quot;(&quot; align=&quot;char&quot;&gt;6.6 (1/15)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>6749</offset><text>Management of RMD patients with COVID-19	Tweets	Percent	 	 Guideline/recommendation (scientific society)	9	60.0 (9/15)	 	 Recommendation (healthcare professional)	5	33.3 (4/15)	 	 Other	1	6.6 (1/15)	 	</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>6954</offset><text>aTweets could include multiple conditions</text></passage><passage><infon key="file">Tab2.xml</infon><infon key="id">Tab2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>6996</offset><text>bTweets could include multiple therapeutic agents</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7046</offset><text>A significant proportion of the tweets (102/242; 42.1%) referred to the COVID-19 Global Rheumatology Alliance registries and encouraged the participation of both healthcare professionals and patients (72/102; 70.5%). Specific rheumatic and musculoskeletal diseases (RMD) were mentioned in a minor proportion of tweets (18/242; 7.4%) (Table 2). Approximately a quarter (64/242; 26.4%) of the tweets discussed specific therapeutic agents for the management of RMDs or COVID-19. Hydroxychloroquine/chloroquine (41 tweets) and tocilizumab (7 tweets) were the most frequently mentioned drugs (Table 2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7644</offset><text>Interestingly, tweets infrequently referred to the special challenges of the COVID-19 pandemic for the management of RMD patients without (43/242; 17.7%) or with COVID-19 infection (15/242; 6.1%) (Table 2): However, the use of telehealth (27/242; 11.1%) was a common theme for the management of RMD patients in the current situation. Notably, only 9 (9/242; 3.7%) tweets addressed patient education in the context of the pandemic. Finally, a third (81/242; 33.4%) of the tweets contained supplementary material, such as resources published by scientific societies (24/242; 9.9%) or scientific journals (32/242; 13.2%).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>8263</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>8274</offset><text>By using Twitter and connecting topics to a specific hashtag it is possible to effectively reach a global audience. Our analysis showed that a relatively small number of the 245 primary tweets which used the hashtag #Covid4Rheum were able to reach an overall engagement in 6916 users and influence of over 6.7 million. Although English was the predominant language used (90.3%), tweets were in 7 different languages and tweet creators were located in 19 different countries, demonstrating that Twitter can reach and connect the global rheumatology community (Table 1). It is noteworthy that the majority of tweets originated from anglophone countries (177/225; 78.6%). This may be due to the overrepresentation of Twitter users in these countries, or resultant of the language barrier for users from other countries.</text></passage><passage><infon key="file">296_2020_4710_Fig1_HTML.jpg</infon><infon key="id">Fig1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>9091</offset><text>Tweet timeline and tweet content examples </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9134</offset><text>Notably, various groups, such as healthcare professionals (HCP), support groups (i.e. LUPUS UK), scientific organizations (i.e. ACR) and scientific journals (i.e. Nature Reviews Rheumatology), engaged with the hashtag. Interestingly, the content analysis showed that different stakeholders of the rheumatology community used Twitter in connection with #Covid4Rheum for various reasons. For example, HCP shared knowledge and experiences concerning COVID-19 related topics, scientific societies were promoting guidelines or health policy-related content, and scientific journals shared and promoted publications (Fig. 1).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9755</offset><text>Importantly, only few patients (2.9%) and support groups (6.5%) engaged with the hashtag, although several tweets encouraged patient participation in the COVID-19 Global Rheumatology Alliance registry. The authors presume that Twitter is less attractive for patients, possibly due to the short message system, in comparison to other social media platforms, such as Facebook or Instagram, which may be more likely to be used by this cohort.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10195</offset><text>At the beginning of the COVID-19 pandemic, there was a significant degree of uncertainty regarding the treatment of RMD patients. By applying digital crowdsourcing, the COVID-19 Global Rheumatology Alliance was rapidly set up. Via Twitter and the use of the specific hashtags such as #Covid4Rheum, collaborations and enrolment of patients were actively promoted. 42.1% of the tweets which used this hashtag referred to the COVID-19 Global Rheumatology Alliance registry and a majority of these tweets encouraged participation (72/102; 70.5%). #Covid4Rheum was used by HCPs, journals and scientific organizations to promote the registry and to share preliminary results and updates. The data from the COVID-19 Global Rheumatology Alliance significantly contributed to the scientific discourse on RMDs and COVID-19. As a result, first major publications were published.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11063</offset><text>The analysis found that 26.4% of the tweets were related to immunosuppressive agents in the context of the COVID-19 pandemic. The main issues were the presumed vulnerability of RMD patients for COVID-19 infection due to immunosuppressive therapy, the management of the hydroxychloroquine shortage and the potential use of immunosuppressive treatment for COVID-19 infections. The results illustrate the importance of these topics for the rheumatological community during the COVID-19 pandemic. Furthermore, they underline the potential of Twitter to foster the exchange of medical knowledge (“from Twitter to bedside”).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11686</offset><text>The COVID-19 pandemic and the wide range of quarantine and security precautions have greatly affected the healthcare for many RMD patients. In particular, telemedicine was rapidly introduced by many clinics to deal with this development. Interestingly, this is also reflected in our analysis of the tweets. In total, 11.1% of the tweets were related to the topic of telemedicine, in particular the requirements for the setup, the implementation and reimbursement.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12150</offset><text>Naturally, social media is very dynamic, as discussions and interpretation of facts can sometimes change rapidly. In particular, unreliable data sets and flawed publications can cause great reputational damage, and indirectly harm patients via uncritical dissemination of false information, as the recent retractions of COVID-19 related publications in The Lancet and The New England Journal of Medicine have illustrated.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12572</offset><text>The limited period of this hashtag analysis and the focus on primary tweets are limitations of this study. Particularly by tweet commenting, the content can be interpreted differently, or debates can be redirected. Likewise, new scientific findings and medical developments can shift the focus of the tweets in another direction, so that an over-representation of certain topics cannot be ruled out. Therefore, analyses of social media content should always be subject to a thorough review and be interpreted within the time frame of its creation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13120</offset><text>This analysis highlights the wide range of opportunities for the use of social media in rheumatology: Digital platforms like Twitter are able to engage with a vast audience and connect different members of the rheumatology community. As Nikipharou et al. already pointed out, social media platforms provide novel ways for opinion sharing, learning and development, which is especially important in times of uncertainties during a pandemic. Notably, social media can effectively increase the impact of scientific publications which might be of interest to researchers and scientific journals alike. Social media can direct attention and increase participation for digital crowdsourcing projects, such as the COVID-19 Global Rheumatology Alliance registries or healthcare policy projects.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13907</offset><text>Our analysis underlines the feasibility of digital data mining for the identification and analysis of hashtag related content on Twitter. Data mining techniques might also be applied to other social media platforms and rheumatology related topics to gain more insight into the content and related stakeholders. As Pérez-Pérez et al. suggested, Twitter content analysis might even support decision making among health-related stakeholders.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14348</offset><text>The potential of social media should progressively be unlocked to enhance communication between all members of the rheumatology community, in particularly with RMD patients, and to enable the setup and participation in research and healthcare-related topics to improve treatment and management of RMDs.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14651</offset><text>In conclusion, social media, Twitter in particular, effectively connects members of the rheumatology community on a global scale, allowing for rapid content-sharing, communication and scientific cooperation (digital crowdsourcing), as this study shows. Moreover, digital data mining of social media content can be used to identify hot topics and blind spots within the field of rheumatology.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>15043</offset><text>Pre-publication archiving</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15069</offset><text>This manuscript has not been subject to pre-publication archiving.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>15136</offset><text>Electronic supplementary material</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>15170</offset><text>Below is the link to the electronic supplementary material.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>15230</offset><text>Publisher's Note</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>15247</offset><text>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>15366</offset><text>Author contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>15387</offset><text>NR and MK designed the study. All authors reviewed and analysed the tweets and contributed to the draft of the manuscript. All authors approved the final version of the manuscript.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title</infon><offset>15568</offset><text>Funding</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">paragraph</infon><offset>15576</offset><text>Open Access funding enabled and organized by Projekt DEAL. No specific funding was received from any funding bodies in the public, commercial or not-for-profit sectors to carry out the work described in this abstract.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title</infon><offset>15794</offset><text>Compliance with ethical standards</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>15828</offset><text>Conflict of interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>15849</offset><text>The authors declare no conflict of interest.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>15894</offset><text>References</text></passage><passage><infon key="fpage">113</infon><infon key="issue">1</infon><infon key="lpage">126</infon><infon key="name_0">surname:Venuturupalli;given-names:RS</infon><infon key="name_1">surname:Sufka;given-names:P</infon><infon key="name_2">surname:Bhana;given-names:S</infon><infon key="pub-id_doi">10.1016/j.rdc.2018.09.010</infon><infon key="pub-id_pmid">30447740</infon><infon key="section_type">REF</infon><infon key="source">Rheum Dis Clin North Am</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2019</infon><offset>15905</offset><text>Digital medicine in rheumatology: challenges and opportunities</text></passage><passage><infon key="fpage">1777</infon><infon key="issue">Suppl 2</infon><infon key="name_0">surname:Collins;given-names:C</infon><infon key="name_1">surname:Campos;given-names:J</infon><infon key="name_2">surname:Isabelle;given-names:A</infon><infon key="name_3">surname:Bhana;given-names:S</infon><infon key="name_4">surname:Jayatilleke;given-names:A</infon><infon key="name_5">surname:Sufka;given-names:P</infon><infon key="pub-id_doi">10.1136/annrheumdis-2018-eular.3486</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">2018</infon><offset>15968</offset><text>AB1385l#rheumjc: 3 year analysis of a twitter based rheumatology journal club</text></passage><passage><infon key="fpage">893</infon><infon key="issue">5</infon><infon key="lpage">899</infon><infon key="name_0">surname:Negron;given-names:JB</infon><infon key="pub-id_doi">10.1007/s00296-019-04249-0</infon><infon key="pub-id_pmid">30778654</infon><infon key="section_type">REF</infon><infon key="source">Rheumatol Int</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2019</infon><offset>16046</offset><text>#EULAR2018: the annual European congress of rheumatology—a twitter hashtag analysis</text></passage><passage><infon key="fpage">208</infon><infon key="issue">Suppl 1</infon><infon key="name_0">surname:Studenic;given-names:P</infon><infon key="name_1">surname:Ospelt;given-names:C</infon><infon key="pub-id_doi">10.1136/annrheumdis-2020-eular.5913</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">2020</infon><offset>16132</offset><text>OP0339׀ALTMETRIC—does social media impact citation rate in rheumatology journals׀</text></passage><passage><infon key="fpage">183</infon><infon key="issue">2</infon><infon key="lpage">190</infon><infon key="name_0">surname:Zimba;given-names:O</infon><infon key="name_1">surname:Radchenko;given-names:O</infon><infon key="name_2">surname:Strilchuk;given-names:L</infon><infon key="pub-id_doi">10.1007/s00296-019-04493-4</infon><infon key="pub-id_pmid">31863133</infon><infon key="section_type">REF</infon><infon key="source">Rheumatol Int</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2020</infon><offset>16218</offset><text>Social media for research, education and practice in rheumatology</text></passage><passage><infon key="fpage">1785</infon><infon key="issue">6</infon><infon key="lpage">1789</infon><infon key="name_0">surname:Pineda;given-names:C</infon><infon key="name_1">surname:Perez-Neri;given-names:I</infon><infon key="name_2">surname:Sandoval;given-names:H</infon><infon key="pub-id_doi">10.1007/s10067-019-04586-2</infon><infon key="pub-id_pmid">31093788</infon><infon key="section_type">REF</infon><infon key="source">Clin Rheumatol</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2019</infon><offset>16284</offset><text>Challenges for social media editors in rheumatology journals: an outlook</text></passage><passage><infon key="name_0">surname:Pollett;given-names:S</infon><infon key="name_1">surname:Rivers;given-names:C</infon><infon key="pub-id_doi">10.1093/cid/ciaa553</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>16357</offset><text>Social media and the new world of scientific communication during the COVID19 pandemic</text></passage><passage><infon key="fpage">293</infon><infon key="issue">6</infon><infon key="lpage">294</infon><infon key="name_0">surname:Robinson;given-names:PC</infon><infon key="name_1">surname:Yazdany;given-names:J</infon><infon key="pub-id_doi">10.1038/s41584-020-0418-0</infon><infon key="pub-id_pmid">32242121</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Rheumatol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2020</infon><offset>16444</offset><text>The COVID-19 global rheumatology alliance: collecting data in a pandemic</text></passage><passage><infon key="name_0">surname:Krusche;given-names:M</infon><infon key="name_1">surname:Burmester;given-names:GR</infon><infon key="name_2">surname:Knitza;given-names:J</infon><infon key="pub-id_doi">10.1136/annrheumdis-2020-217697</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>16517</offset><text>Digital crowdsourcing: unleashing its power in rheumatology</text></passage><passage><infon key="name_0">surname:Sharma;given-names:C</infon><infon key="name_1">surname:Whittle;given-names:S</infon><infon key="name_2">surname:Haghighi;given-names:PD</infon><infon key="name_3">surname:Burstein;given-names:F</infon><infon key="name_4">surname:Sa'adon;given-names:R</infon><infon key="name_5">surname:Keen;given-names:HI</infon><infon key="pub-id_doi">10.1136/annrheumdis-2020-217333</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>16577</offset><text>Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis</text></passage><passage><infon key="fpage">57</infon><infon key="issue">1</infon><infon key="lpage">69</infon><infon key="name_0">surname:Yang;given-names:J</infon><infon key="name_1">surname:Li;given-names:Y</infon><infon key="name_2">surname:Liu;given-names:Q</infon><infon key="name_3">surname:Li;given-names:L</infon><infon key="name_4">surname:Feng;given-names:A</infon><infon key="name_5">surname:Wang;given-names:T</infon><infon key="name_6">surname:Zheng;given-names:S</infon><infon key="name_7">surname:Xu;given-names:A</infon><infon key="name_8">surname:Lyu;given-names:J</infon><infon key="pub-id_doi">10.1111/jebm.12373</infon><infon key="pub-id_pmid">32086994</infon><infon key="section_type">REF</infon><infon key="source">J Evid Based Med</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2020</infon><offset>16694</offset><text>Brief introduction of medical database and data mining technology in big data era</text></passage><passage><infon key="fpage">1204</infon><infon key="issue">6</infon><infon key="lpage">1206</infon><infon key="name_0">surname:Wallace;given-names:ZS</infon><infon key="name_1">surname:Bhana;given-names:S</infon><infon key="name_2">surname:Hausmann;given-names:JS</infon><infon key="name_3">surname:Robinson;given-names:PC</infon><infon key="name_4">surname:Sufka;given-names:P</infon><infon key="name_5">surname:Sirotich;given-names:E</infon><infon key="name_6">surname:Yazdany;given-names:J</infon><infon key="name_7">surname:Grainger;given-names:R</infon><infon key="pub-id_doi">10.1093/rheumatology/keaa191</infon><infon key="pub-id_pmid">32374851</infon><infon key="section_type">REF</infon><infon key="source">Rheumatology (Oxford)</infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="year">2020</infon><offset>16776</offset><text>The rheumatology community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance</text></passage><passage><infon key="fpage">859</infon><infon key="issue">7</infon><infon key="lpage">866</infon><infon key="name_0">surname:Gianfrancesco;given-names:M</infon><infon key="name_1">surname:Hyrich;given-names:KL</infon><infon key="name_10">surname:Mateus;given-names:EF</infon><infon key="name_11">surname:Rush;given-names:S</infon><infon key="name_12">surname:Schmajuk;given-names:G</infon><infon key="name_13">surname:Simard;given-names:J</infon><infon key="name_14">surname:Strangfeld;given-names:A</infon><infon key="name_15">surname:Trupin;given-names:L</infon><infon key="name_16">surname:Wysham;given-names:KD</infon><infon key="name_17">surname:Bhana;given-names:S</infon><infon key="name_18">surname:Costello;given-names:W</infon><infon key="name_19">surname:Grainger;given-names:R</infon><infon key="name_2">surname:Al-Adely;given-names:S</infon><infon key="name_20">surname:Hausmann;given-names:JS</infon><infon key="name_21">surname:Liew;given-names:JW</infon><infon key="name_22">surname:Sirotich;given-names:E</infon><infon key="name_23">surname:Sufka;given-names:P</infon><infon key="name_24">surname:Wallace;given-names:ZS</infon><infon key="name_25">surname:Yazdany;given-names:J</infon><infon key="name_26">surname:Machado;given-names:PM</infon><infon key="name_27">surname:Robinson;given-names:PC</infon><infon key="name_28">surname:Alliance;given-names:C-GR</infon><infon key="name_3">surname:Carmona;given-names:L</infon><infon key="name_4">surname:Danila;given-names:MI</infon><infon key="name_5">surname:Gossec;given-names:L</infon><infon key="name_6">surname:Izadi;given-names:Z</infon><infon key="name_7">surname:Jacobsohn;given-names:L</infon><infon key="name_8">surname:Katz;given-names:P</infon><infon key="name_9">surname:Lawson-Tovey;given-names:S</infon><infon key="pub-id_doi">10.1136/annrheumdis-2020-217871</infon><infon key="pub-id_pmid">32471903</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">2020</infon><offset>16901</offset><text>Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry</text></passage><passage><infon key="fpage">871</infon><infon key="issue">7</infon><infon key="lpage">873</infon><infon key="name_0">surname:Sirotich;given-names:E</infon><infon key="name_1">surname:Dillingham;given-names:S</infon><infon key="name_2">surname:Grainger;given-names:R</infon><infon key="name_3">surname:Hausmann;given-names:JS</infon><infon key="name_4">surname:Committee;given-names:C-GRAS</infon><infon key="pub-id_doi">10.1002/acr.24257</infon><infon key="pub-id_pmid">32386125</infon><infon key="section_type">REF</infon><infon key="source">Arthritis Care Res (Hoboken)</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">2020</infon><offset>17076</offset><text>Capturing patient-reported outcomes during the COVID-19 pandemic: development of the COVID-19 global rheumatology alliance patient experience survey</text></passage><passage><infon key="name_0">surname:Sattui;given-names:SE</infon><infon key="name_1">surname:Liew;given-names:JW</infon><infon key="name_10">surname:Robinson;given-names:PC</infon><infon key="name_11">surname:Sirotich;given-names:E</infon><infon key="name_12">surname:Ugarte-Gil;given-names:MF</infon><infon key="name_13">surname:Webb;given-names:K</infon><infon key="name_14">surname:Young;given-names:KJ</infon><infon key="name_15">surname:Kim;given-names:AHJ</infon><infon key="name_16">surname:Sparks;given-names:JA</infon><infon key="name_2">surname:Graef;given-names:ER</infon><infon key="name_3">surname:Coler-Reilly;given-names:A</infon><infon key="name_4">surname:Berenbaum;given-names:F</infon><infon key="name_5">surname:Duarte-Garcia;given-names:A</infon><infon key="name_6">surname:Harrison;given-names:C</infon><infon key="name_7">surname:Konig;given-names:MF</infon><infon key="name_8">surname:Korsten;given-names:P</infon><infon key="name_9">surname:Putman;given-names:MS</infon><infon key="pub-id_doi">10.1080/1744666X.2020.1792778</infon><infon key="section_type">REF</infon><infon key="source">Expert Rev Clin Immunol</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>17225</offset><text>Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19</text></passage><passage><infon key="name_0">surname:Perniola;given-names:S</infon><infon key="name_1">surname:Alivernini;given-names:S</infon><infon key="name_10">surname:Peluso;given-names:G</infon><infon key="name_11">surname:Capacci;given-names:A</infon><infon key="name_12">surname:Gremese;given-names:E</infon><infon key="name_2">surname:Varriano;given-names:V</infon><infon key="name_3">surname:Paglionico;given-names:A</infon><infon key="name_4">surname:Tanti;given-names:G</infon><infon key="name_5">surname:Rubortone;given-names:P</infon><infon key="name_6">surname:Lanzo;given-names:L</infon><infon key="name_7">surname:Melpignano;given-names:F</infon><infon key="name_8">surname:Tur;given-names:C</infon><infon key="name_9">surname:De Lorenzis;given-names:E</infon><infon key="pub-id_doi">10.1136/annrheumdis-2020-218022</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>17329</offset><text>Telemedicine will not keep us apart in COVID-19 pandemic</text></passage><passage><infon key="fpage">e258</infon><infon key="issue">5</infon><infon key="name_0">surname:Kirby;given-names:T</infon><infon key="pub-id_doi">10.1016/S2665-9913(20)30094-1</infon><infon key="pub-id_pmid">32518921</infon><infon key="section_type">REF</infon><infon key="source">Lancet Rheumatol</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">2020</infon><offset>17386</offset><text>Rheumatologists rapidly adjust patient care during COVID-19 pandemic</text></passage><passage><infon key="fpage">1820</infon><infon key="issue">10240</infon><infon key="name_0">surname:Mehra;given-names:MR</infon><infon key="name_1">surname:Ruschitzka;given-names:F</infon><infon key="name_2">surname:Patel;given-names:AN</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)31324-6</infon><infon key="pub-id_pmid">32511943</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">395</infon><infon key="year">2020</infon><offset>17455</offset><text>Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis</text></passage><passage><infon key="fpage">e102</infon><infon key="issue">25</infon><infon key="name_0">surname:Mehra;given-names:MR</infon><infon key="name_1">surname:Desai;given-names:SS</infon><infon key="name_2">surname:Kuy;given-names:S</infon><infon key="name_3">surname:Henry;given-names:TD</infon><infon key="name_4">surname:Patel;given-names:AN</infon><infon key="pub-id_doi">10.1056/NEJMoa2007621</infon><infon key="pub-id_pmid">32356626</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">382</infon><infon key="year">2020</infon><offset>17589</offset><text>Cardiovascular disease, drug therapy, and mortality in COVID-19</text></passage><passage><infon key="fpage">1245</infon><infon key="issue">8</infon><infon key="lpage">1246</infon><infon key="name_0">surname:Nikiphorou;given-names:E</infon><infon key="name_1">surname:Studenic;given-names:P</infon><infon key="name_2">surname:Alunno;given-names:A</infon><infon key="name_3">surname:Canavan;given-names:M</infon><infon key="name_4">surname:Jani;given-names:M</infon><infon key="name_5">surname:Berenbaum;given-names:F</infon><infon key="pub-id_doi">10.1136/annrheumdis-2017-212273</infon><infon key="pub-id_pmid">29203633</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">2018</infon><offset>17653</offset><text>‘Twitterland’: a brave new world?</text></passage><passage><infon key="name_0">surname:Luc;given-names:JGY</infon><infon key="name_1">surname:Archer;given-names:MA</infon><infon key="name_10">surname:Antonoff;given-names:MB</infon><infon key="name_2">surname:Arora;given-names:RC</infon><infon key="name_3">surname:Bender;given-names:EM</infon><infon key="name_4">surname:Blitz;given-names:A</infon><infon key="name_5">surname:Cooke;given-names:DT</infon><infon key="name_6">surname:Hlci;given-names:TN</infon><infon key="name_7">surname:Kidane;given-names:B</infon><infon key="name_8">surname:Ouzounian;given-names:M</infon><infon key="name_9">surname:Varghese;given-names:TK;suffix:Jr</infon><infon key="section_type">REF</infon><infon key="source">Does tweeting improve citations?</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>17691</offset></passage><passage><infon key="fpage">e12610</infon><infon key="issue">8</infon><infon key="name_0">surname:Perez-Perez;given-names:M</infon><infon key="name_1">surname:Perez-Rodriguez;given-names:G</infon><infon key="name_2">surname:Fdez-Riverola;given-names:F</infon><infon key="name_3">surname:Lourenco;given-names:A</infon><infon key="pub-id_doi">10.2196/12610</infon><infon key="pub-id_pmid">31411142</infon><infon key="section_type">REF</infon><infon key="source">J Med Internet Res</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2019</infon><offset>17692</offset><text>Using twitter to understand the human bowel disease community: exploratory analysis of key topics</text></passage><passage><infon key="fpage">1033</infon><infon key="issue">10229</infon><infon key="lpage">1034</infon><infon key="name_0">surname:Mehta;given-names:P</infon><infon key="name_1">surname:McAuley;given-names:DF</infon><infon key="name_2">surname:Brown;given-names:M</infon><infon key="name_3">surname:Sanchez;given-names:E</infon><infon key="name_4">surname:Tattersall;given-names:RS</infon><infon key="name_5">surname:Manson;given-names:JJ</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30628-0</infon><infon key="pub-id_pmid">32192578</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">395</infon><infon key="year">2020</infon><offset>17790</offset><text>COVID-19: consider cytokine storm syndromes and immunosuppression</text></passage><passage><infon key="fpage">732</infon><infon key="issue">15</infon><infon key="lpage">739</infon><infon key="name_0">surname:Yao;given-names:X</infon><infon key="name_1">surname:Ye;given-names:F</infon><infon key="name_10">surname:Zhan;given-names:S</infon><infon key="name_11">surname:Lu;given-names:R</infon><infon key="name_12">surname:Li;given-names:H</infon><infon key="name_13">surname:Tan;given-names:W</infon><infon key="name_14">surname:Liu;given-names:D</infon><infon key="name_2">surname:Zhang;given-names:M</infon><infon key="name_3">surname:Cui;given-names:C</infon><infon key="name_4">surname:Huang;given-names:B</infon><infon key="name_5">surname:Niu;given-names:P</infon><infon key="name_6">surname:Liu;given-names:X</infon><infon key="name_7">surname:Zhao;given-names:L</infon><infon key="name_8">surname:Dong;given-names:E</infon><infon key="name_9">surname:Song;given-names:C</infon><infon key="pub-id_doi">10.1093/cid/ciaa237</infon><infon key="pub-id_pmid">32150618</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="volume">71</infon><infon key="year">2020</infon><offset>17856</offset><text>In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</text></passage><passage><infon key="fpage">155</infon><infon key="issue">3</infon><infon key="lpage">166</infon><infon key="name_0">surname:Schrezenmeier;given-names:E</infon><infon key="name_1">surname:Dorner;given-names:T</infon><infon key="pub-id_doi">10.1038/s41584-020-0372-x</infon><infon key="pub-id_pmid">32034323</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Rheumatol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2020</infon><offset>18030</offset><text>Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology</text></passage><passage><infon key="name_0">surname:Goyal;given-names:M</infon><infon key="pub-id_doi">10.1136/annrheumdis-2020-217658</infon><infon key="section_type">REF</infon><infon key="source">Ann Rheum Dis</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>18120</offset><text>SLE patients are not immune to COVID-19: importance of sending the right message across</text></passage><passage><infon key="fpage">347</infon><infon key="issue">7</infon><infon key="lpage">348</infon><infon key="name_0">surname:Pinto;given-names:AJ</infon><infon key="name_1">surname:Dunstan;given-names:DW</infon><infon key="name_2">surname:Owen;given-names:N</infon><infon key="name_3">surname:Bonfa;given-names:E</infon><infon key="name_4">surname:Gualano;given-names:B</infon><infon key="pub-id_doi">10.1038/s41584-020-0427-z</infon><infon key="pub-id_pmid">32355296</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Rheumatol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2020</infon><offset>18208</offset><text>Combating physical inactivity during the COVID-19 pandemic</text></passage></document></collection>
